AMGEN INC (AMGN) Stock Fundamental Analysis
NASDAQ:AMGN • US0311621009
382.87 USD
+3.45 (+0.91%)
At close: Feb 24, 2026
381.02 USD
-1.85 (-0.48%)
Pre-Market: 2/25/2026, 4:01:29 AM
Taking everything into account, AMGN scores 5 out of 10 in our fundamental rating. AMGN was compared to 521 industry peers in the Biotechnology industry. AMGN scores excellent on profitability, but there are concerns on its financial health. AMGN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- AMGN had positive earnings in the past year.
- AMGN had a positive operating cash flow in the past year.
- In the past 5 years AMGN has always been profitable.
- In the past 5 years AMGN always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 8.51%, AMGN belongs to the best of the industry, outperforming 93.09% of the companies in the same industry.
- The Return On Equity of AMGN (89.06%) is better than 99.23% of its industry peers.
- The Return On Invested Capital of AMGN (16.85%) is better than 96.55% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for AMGN is below the industry average of 18.24%.
- The 3 year average ROIC (14.35%) for AMGN is below the current ROIC(16.85%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROIC | 16.85% |
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
1.3 Margins
- AMGN has a better Profit Margin (20.98%) than 94.05% of its industry peers.
- In the last couple of years the Profit Margin of AMGN has declined.
- The Operating Margin of AMGN (34.19%) is better than 97.50% of its industry peers.
- AMGN's Operating Margin has improved in the last couple of years.
- The Gross Margin of AMGN (73.30%) is better than 83.11% of its industry peers.
- In the last couple of years the Gross Margin of AMGN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% |
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so AMGN is creating value.
- The number of shares outstanding for AMGN has been increased compared to 1 year ago.
- The number of shares outstanding for AMGN has been reduced compared to 5 years ago.
- AMGN has a better debt/assets ratio than last year.
2.2 Solvency
- The Debt to FCF ratio of AMGN is 6.74, which is on the high side as it means it would take AMGN, 6.74 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 6.74, AMGN belongs to the best of the industry, outperforming 91.36% of the companies in the same industry.
- A Debt/Equity ratio of 5.78 is on the high side and indicates that AMGN has dependencies on debt financing.
- With a Debt to Equity ratio value of 5.78, AMGN is not doing good in the industry: 81.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Altman-Z | N/A |
ROIC/WACC2.02
WACC8.33%
2.3 Liquidity
- A Current Ratio of 1.14 indicates that AMGN should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.14, AMGN is not doing good in the industry: 84.84% of the companies in the same industry are doing better.
- AMGN has a Quick Ratio of 1.14. This is a bad value and indicates that AMGN is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of AMGN (0.90) is worse than 86.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
- AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.24%, which is quite good.
- AMGN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.65% yearly.
- Looking at the last year, AMGN shows a quite strong growth in Revenue. The Revenue has grown by 9.95% in the last year.
- AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.65% yearly.
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
3.2 Future
- AMGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.94% yearly.
- AMGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y3.12%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
EPS Next 5Y4.94%
Revenue Next Year2.04%
Revenue Next 2Y2.46%
Revenue Next 3Y1.68%
Revenue Next 5Y3.16%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 17.52, AMGN is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of AMGN indicates a rather cheap valuation: AMGN is cheaper than 95.20% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 26.98. AMGN is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 16.99, the valuation of AMGN can be described as correct.
- 94.82% of the companies in the same industry are more expensive than AMGN, based on the Price/Forward Earnings ratio.
- AMGN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.52 | ||
| Fwd PE | 16.99 |
4.2 Price Multiples
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMGN indicates a rather cheap valuation: AMGN is cheaper than 94.82% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.45 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of AMGN may justify a higher PE ratio.
PEG (NY)5.61
PEG (5Y)3.1
EPS Next 2Y3.35%
EPS Next 3Y2.5%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 2.62%, AMGN has a reasonable but not impressive dividend return.
- AMGN's Dividend Yield is rather good when compared to the industry average which is at 1.17. AMGN pays more dividend than 98.85% of the companies in the same industry.
- AMGN's Dividend Yield is a higher than the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.62% |
5.2 History
- On average, the dividend of AMGN grows each year by 9.41%, which is quite nice.
- AMGN has been paying a dividend for at least 10 years, so it has a reliable track record.
- AMGN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.41%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
- The dividend of AMGN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
382.87
+3.45 (+0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-03 2026-02-03/amc
Earnings (Next)04-29 2026-04-29/amc
Inst Owners83.87%
Inst Owner Change2.27%
Ins Owners0.06%
Ins Owner Change-0.93%
Market Cap206.17B
Revenue(TTM)36.75B
Net Income(TTM)7.71B
Analysts71.71
Price Target341.81 (-10.72%)
Short Float %2.47%
Short Ratio4.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.62% |
Yearly Dividend9.01
Dividend Growth(5Y)9.41%
DP0%
Div Incr Years13
Div Non Decr Years13
Ex-Date02-13 2026-02-13 (2.52)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.92%
Min EPS beat(2)9.56%
Max EPS beat(2)10.28%
EPS beat(4)4
Avg EPS beat(4)10.8%
Min EPS beat(4)9.56%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)6.29%
EPS beat(12)11
Avg EPS beat(12)5.41%
EPS beat(16)14
Avg EPS beat(16)4.51%
Revenue beat(2)2
Avg Revenue beat(2)3.3%
Min Revenue beat(2)2.11%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.61%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.85%
PT rev (3m)4.41%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)-4.8%
EPS NY rev (1m)0.47%
EPS NY rev (3m)2.41%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)2.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.52 | ||
| Fwd PE | 16.99 | ||
| P/S | 5.61 | ||
| P/FCF | 25.45 | ||
| P/OCF | 20.7 | ||
| P/B | 23.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)21.85
EY5.71%
EPS(NY)22.53
Fwd EY5.89%
FCF(TTM)15.04
FCFY3.93%
OCF(TTM)18.49
OCFY4.83%
SpS68.25
BVpS16.08
TBVpS-59.98
PEG (NY)5.61
PEG (5Y)3.1
Graham Number88.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROCE | 19.3% | ||
| ROIC | 16.85% | ||
| ROICexc | 19.6% | ||
| ROICexgc | 73.08% | ||
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% | ||
| FCFM | 22.04% |
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
ROICexc(3y)16.88%
ROICexc(5y)18.44%
ROICexgc(3y)72.7%
ROICexgc(5y)79.08%
ROCE(3y)16.43%
ROCE(5y)17.69%
ROICexgc growth 3Y-3.21%
ROICexgc growth 5Y2.03%
ROICexc growth 3Y4.63%
ROICexc growth 5Y5.17%
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
F-Score7
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 5.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 105.05% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | N/A |
F-Score7
WACC8.33%
ROIC/WACC2.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)4.09%
Cap/Sales(5y)3.84%
Profit Quality(3y)156.25%
Profit Quality(5y)149.01%
High Growth Momentum
Growth
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
EPS Next Y3.12%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
EPS Next 5Y4.94%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
Revenue Next Year2.04%
Revenue Next 2Y2.46%
Revenue Next 3Y1.68%
Revenue Next 5Y3.16%
EBIT growth 1Y73.11%
EBIT growth 3Y16.9%
EBIT growth 5Y12.12%
EBIT Next Year31.54%
EBIT Next 3Y9.81%
EBIT Next 5Y8.21%
FCF growth 1Y-22.07%
FCF growth 3Y-2.67%
FCF growth 5Y-3.91%
OCF growth 1Y-13.33%
OCF growth 3Y0.81%
OCF growth 5Y-1.05%
AMGEN INC / AMGN FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to AMGN.
What is the valuation status of AMGEN INC (AMGN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AMGEN INC (AMGN). This can be considered as Fairly Valued.
What is the profitability of AMGN stock?
AMGEN INC (AMGN) has a profitability rating of 8 / 10.
How financially healthy is AMGEN INC?
The financial health rating of AMGEN INC (AMGN) is 3 / 10.
What is the earnings growth outlook for AMGEN INC?
The Earnings per Share (EPS) of AMGEN INC (AMGN) is expected to grow by 3.12% in the next year.